Everyone Warned Me About The Side Effects Of GLP-1s. Nobody Warned Me About The Judgment. – BuzzFeed
Everyone Warned Me About The Side Effects Of GLP-1s. Nobody Warned Me About The Judgment. BuzzFeedObesity Should Be Treated…
Another weight-loss drug revolution is coming
If you thought slimming jabs had made a big splash, brace yourself, as the next big shake-up of…
Why Viral Home Remedies Won’t Always Help Your Hair Colour, Expert Explains
New Delhi: As hair colour becomes increasingly popular among young Indians, choosing the right shade and maintaining it…
Subscribe to The Australian | Newspaper home delivery, website, iPad, iPhone & Android apps
The Australian Digital subscription costs $24 (min. cost) charged every 4 weeks for a duration of 52 weeks,…
Knowledge keepers creating inventory of medicinal plants found on land shared by Prairie farmers
Linda Obey-Lavallee learned all about plants — how to read them, how to pick them properly, their medicinal…
Nova Scotia regulates naturopathic doctors but scope of work still unclear
Listen to this article Estimated 3 minutes The audio version of this article is generated by AI-based technology.…
Regeneron (REGN) Says EMA Accepted Review for Otarmeni Application
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the 10 Best Debt-Free S&P 500 Stocks to Buy Now. On…
Doctor’s drug prescribing had ‘direct role’ in deaths
A former medical practitioner who was the subject of multiple red flags played a direct role in the…
Keeping rebound weight off after stopping GLP-1 drugs
For many, GLP-1 (glucagon-like peptide-1) drugs like tirzepatide and semaglutide offered an ideal solution to diabetes and weight…
Popular over-the-counter gas medication sold in US recalled for possible contamination
Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The…
Weight-loss doctor claims smear campaign as authorities probe injectable drugs
Dr Tommie Smook denies his practice supplied any of the weight-loss injections recently recalled by Sahpra. Be among…
Lilly’s triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and its complications
In TRIUMPH-1, participants on retatrutide 12 mg lost an average of 70.3 lbs (28.3%) over 80 weeks, with…